We have previously demonstrated that 1131 base pairs (bp) of the human gonadotropin-releasing hormone (hGnRH) gene promoter can target simian virus 40 T antigen expression to GnRH neurons in transgenic mice. In these animals, GnRH neurons were transformed before they migrated to their final location in the rostral hypothalamus, complicating an analysis of cell-specific expression. To localize regions of the hGnRH promoter that are important for cell-specific expression, we created transgenic mice with various 5-flanking regions of the hGnRH gene fused to the luciferase reporter gene. When 3828 or 1131 bp of the hGnRH promoter 5-flanking DNA were used (؊3828/؉5LUC and ؊1131/؉5LUC, respectively), luciferase expression in adult transgenic mice was observed in the rostral hypothalamus and olfactory tissues, regions which have been shown to be loci of GnRH-expressing neurons. Luciferase expression was not observed in other brain or peripheral tissues. Double-labeled in situ hybridization further demonstrated that luciferase expression was invariably colocalized with GnRH expression. When transgenic animals were created with a construct consisting of 484 bp of the hGnRH 5-flanking DNA fused to the luciferase gene (؊484/؉5LUC), luciferase expression was not observed in the hypothalamus or in olfactory tissues. This is the first report localizing DNA sequences responsible for cell-specific expression of the GnRH gene in vivo.
We have previously demonstrated that 1131 base pairs (bp) of the human gonadotropin-releasing hormone (hGnRH) gene promoter can target simian virus 40 T antigen expression to GnRH neurons in transgenic mice. In these animals, GnRH neurons were transformed before they migrated to their final location in the rostral hypothalamus, complicating an analysis of cell-specific expression. To localize regions of the hGnRH promoter that are important for cell-specific expression, we created transgenic mice with various 5-flanking regions of the hGnRH gene fused to the luciferase reporter gene. When 3828 or 1131 bp of the hGnRH promoter 5-flanking DNA were used (؊3828/؉5LUC and ؊1131/؉5LUC, respectively), luciferase expression in adult transgenic mice was observed in the rostral hypothalamus and olfactory tissues, regions which have been shown to be loci of GnRH-expressing neurons. Luciferase expression was not observed in other brain or peripheral tissues. Double-labeled in situ hybridization further demonstrated that luciferase expression was invariably colocalized with GnRH expression. When transgenic animals were created with a construct consisting of 484 bp of the hGnRH 5-flanking DNA fused to the luciferase gene (؊484/؉5LUC), luciferase expression was not observed in the hypothalamus or in olfactory tissues. This is the first report localizing DNA sequences responsible for cell-specific expression of the GnRH gene in vivo.
The neurohormone gonadotropin-releasing hormone (GnRH) 1 is a decapeptide that is released from the hypothalamus and regulates the synthesis and release of the pituitary gonadotropins. It has become increasingly clear that the precise coordinated release and expression of GnRH are essential for proper function of the mammalian reproductive system. For example, patients with Kallmann's syndrome do not appear to contain GnRH neurons in the appropriate locations within the hypothalamus due to a failure of the GnRH neurons to migrate from the olfactory placode during development, which manifests as hypogonadotropic hypogonadism (1) (2) (3) . Until recently, the study of the intracellular mechanisms regulating the release and expression of GnRH has been complicated by both the low numbers of GnRH neurons, as few as 800 in the mouse brain (4) , and their scattered distribution from the hypothalamus to the olfactory bulb (5, 44) .
In humans the GnRH gene consists of four exons and three introns (6 -11) , and its expression is limited to a small number of neurons in the brain, to gonadal and mammary tissue (12) , and to human placental tissue (10, 13) . Interestingly, GnRH expression displays a tissue specificity since the initiation site for placental GnRH expression is different than the initiation site for hypothalamic GnRH expression (10, 13) . Recently, transgenic technology has given researchers the tools to study physiological and molecular aspects of the GnRH neuron. By targeting the SV40 T antigen oncogene to mouse GnRH neurons using the rat (GT1 cells (14) ) or human (GN11 and NLT cells (15) ) GnRH promoter, it has been possible to obtain a number of transformed GnRH-releasing cell lines. These cells possess a neuronal morphology, express and release GnRH, and respond to secretagogues in a manner consistent with that seen in GnRH neurons in vivo and in vitro. These cell lines have proven to be invaluable for studying the regulation of GnRH expression (16) , processing (17) , and release (18, 19) and for examining the electrophysiological properties of GnRH neurons (20, 21) .
It is not clear at this time, however, what transcription factors or cis-regulatory elements are important for initiating and regulating the hypothalamic expression of hGnRH. The studies performed by our group using Ϫ1131 bp of the hGnRH promoter to target tumorigenesis in transgenic mice had appeared to transform only GnRH neurons (15) , suggesting that this region of the hGnRH promoter was sufficient to direct gene expression to the GnRH neuron. However, since these neurons may not have completely differentiated before they were transformed and did not migrate to their final location in the forebrain, it was unclear whether this portion of the hGnRH promoter was actually the minimal promoter needed to appropriately direct and regulate the normal expression of GnRH.
We therefore sought to target expression of the luciferase reporter gene (22) with fragments of the promoter for the hGnRH gene. The luciferase gene is an extremely sensitive reporter, which is a quality necessary for use in the study of the physiological and developmental regulation of the sparsely distributed GnRH neurons. By linking various portions of the GnRH promoter to a luciferase reporter and creating transgenic animals with these constructs, it has been possible to examine the anatomical pattern of expression of luciferase as an assay of hGnRH promoter activity. Series of anatomical and physiological analyses have illustrated that luciferase expression that is driven by a sufficient segment of the hGnRH promoter is correlated with the expression of the endogenous GnRH gene. These studies localize a cis-regulatory region between Ϫ1131 and Ϫ484 bp upstream of the GnRH gene, which is essential for the appropriate expression of GnRH in the brain. Additionally, these studies demonstrate that appropriate gonadal steroid regulation of GnRH expression requires gene elements present within 3828 base pairs of the hGnRH gene.
EXPERIMENTAL PROCEDURES
Transgenic Animal Construction-Transgenic animals were constructed by injecting a purified linear DNA fragment containing a GnRH/LUC construct free of vector DNA sequences into fertilized mouse oocytes as described previously by Radovick et al. (15) . The hGnRH promoter fragments contained a variable amount of 5Ј-flanking DNA, but each had a common 3Ј end point at ϩ5 bp. Oocytes were then transferred into pseudo-pregnant foster mothers. Transgenic animals were identified by Southern blot analysis with a 1.2-kilobase pair LUC probe consisting of the coding sequence of the LUC gene using standard procedures. Briefly, EcoRI-digested mouse tail DNA was separated on a 0.8% agarose gel, transferred to GeneScreen Plus hybridization transfer membrane (DuPont NEN), UV cross-linked for 1.5 min, and placed into hybridization solution (46% formamide, 0.91 M NaCl, 9.1% dextran sulfate, and 1.8% SDS) for at least 5 h at 42°C. Probe (1,000,000 cpm/ml hybridization solution) was mixed with 100 g of salmon sperm/ml of hybridization solution, heat denatured for 5 min, and added to the hybridization solution overnight at 42°C. The blots were then rinsed three times with 2 ϫ SSC and washed for 30 min with 2 ϫ SSC and 1% SDS at 65°C.
Luciferase Assay of Animal Tissues-Animals were sacrificed by CO 2 narcosis and cervical dislocation. The rostral hypothalamus was dissected in a single fragment consisting rostrocaudally of tissue from the anterior edge of the mammillary bodies to a point just anterior of the optic chiasm, 1 mm laterally beyond the lateral aspect of the median eminence and 3 mm dorsally. The olfactory tissue was dissected to include both olfactory bulbs and the tissue rostral to the hypothalamic section; again, the dorsal incision was 3 mm deep. The caudal hypothalamus included the region from the rostral aspect of the mammillary bodies to a point 1 mm caudal to the mammillary bodies and with the same dorsal and lateral parameters as those taken for the rostral hypothalamus. Small sections were taken of the remaining tissues with less care taken to consistently target a specific intra-anatomical location within each organ or tissue. In most cases, however, whole regions were removed for homogenization. Tissues were removed and placed in 1 ml of lysis buffer (25 mM glycylglycine, 15 mM MgSO 4 , 4 mM EGTA, 1% Triton X-100, and 1 mM dithiothreitol) homogenized with a Polytron tissue homogenizer (Brinkmann Instruments). 300 l of the homogenate was then removed and centrifuged for 5 min at 15,000 ϫ g, and 200 l of the supernatant was assayed for luciferase activity.
Luciferase assays were done in a Lumat LB9501 luminometer (Berthold Systems Inc., Pittsburgh, PA). Samples were injected with 100 l of luciferin (0.75 mM) and 100 l of assay buffer (25 mM glycylglycine, 15 mM MgSO 4 , 4 mM EGTA, 15 mM KPO 4 , 3 mM dithiothreitol, and 3 mM ATP), and luminescence was measured for 20 s in relative light units. The relative light units were then normalized for sample size by correcting for protein content. Protein assays were done using a Bio-Rad protein assay and bovine serum albumin standards.
Histology-Double-labeled in situ hybridization histochemical analyses of the hypothalamus and the organum vasculosum of the lamina terminalis (OVLT) of four different lines of Ϫ3828/ϩ5LUC transgenic animals (three males and one female) and two different lines of Ϫ1131/ ϩ5LUC transgenic animals (one male and one female) were performed using antisense oligonucleotide probes to mouse GnRH and luciferase message. A labeled digoxigenin oligonucleotide (1 l of digoxigenin/ slide) corresponding to the decapeptide portion of the mouse GnRH gene was used to label GnRH mRNA, and three 35 S-labeled (250,000 cpm/section, 750,000 cpm/slide) 48-mer oligonucleotides against luciferase (bases 1464 -1511, bases 321-368, and bases 1152-1105 (22)) were used as probes to label luciferase expression.
Sex Steroid Treatments of Transgenic Mice-Animals were gonadectomized under light avertin anesthesia (100% avertin ϭ 10 mg of tribromyl ethanol in 10 ml of tert-amyl ethanol). In males, the testes were removed through a ventral incision made in the abdomen. Sham castrated animals received a ventral incision, but the testes remained intact. In females, the ovaries were removed through a dorsal incision, and sham ovariectomized animals also received a dorsal incision. Males received a pellet of either testosterone (5 mg/pellet) or cholesterol (5 mg/pellet) while females received a pellet of 17␤-estradiol (0.5 mg/ pellet) or cholesterol (5 mg/pellet), which was inserted dorsally with a 10-gauge trochar. All steroid pellets and the trochar were obtained from Innovative Research of America (Toledo, OH). The incisions were sutured, and the animals were allowed to recover for 2 weeks. Animals were checked daily to ensure that the wounds were healing properly.
Radioimmunoassays of ␤-Estradiol and Testosterone-Immunoreactive ␤-estradiol and testosterone were determined by radioimmunoassays using double antibody kits (ICN Biomedicals, Inc., Costa Mesa, CA). The level of sensitivity of the ␤-estradiol radioimmunoassay was 10 pg/ml with an intra-assay coefficient of variation (cv) of between 10 and 6% at the levels measured. The level of sensitivity was 100 pg/ml with a cv of 6% at the levels measured.
Developmental Expression of GnRH-Transgenic mice (Ϫ3828/ ϩ5LUC and Ϫ1131/ϩ5LUC) were sacrificed with CO 2 at a variety of time points following birth (see Fig. 5 ). For prepubertal mice, the entire brain was homogenized and assayed for luciferase expression. For adult mice, luciferase expression from the hypothalamus and the olfactory cortex was combined to give the total value. Dissections were performed as described above.
Experimental Animals-Animal studies were conducted in accordance with the principles and procedures outlined in the NIH Guidelines for the Care and Use of Experimental Animals.
RESULTS

A Region of the 5Ј Flank of the hGnRH Gene Is Essential to Target Expression of a Reporter Gene in Transgenic Mice to the
Hypothalamus-Transgenic animals were created using either Ϫ3828, Ϫ1131, or Ϫ484 bp of the hGnRH gene with a common 3Ј end point of ϩ5 fused to the luciferase reporter gene (Ϫ3828/ ϩ5LUC, Ϫ1131/ϩ5LUC, and Ϫ484/ϩ5LUC, respectively). Table I indicates the number of founder animals from each line that was obtained and the offspring that have been evaluated in this study. At least three founder lines from each construct were obtained, and these lines were bred to generate F1 and later generations. Fig. 1a illustrates the luciferase activity present in selected tissue extracts from a representative animal bearing the Ϫ3828/ϩ5LUC transgene. Luciferase activity, when corrected for protein concentration in the tissue extract, was detected in hypothalamic and olfactory tissues but not in cortical, cerebellar, or other non-neural tissues. Expression in the hypothalamus was at least 50-fold greater than in any peripheral tissues. Non-transgenic animals (not shown) had no significant luciferase activity in these same tissues, indicating the specificity of this reporter gene assay for detecting GnRH gene expression in these tissues.
Similar results were obtained with the Ϫ1131/ϩ5LUC construct. In a representative animal shown in Fig. 1b , both hypothalamic tissue and to a lesser extent olfactory tissue expressed the transgene at levels equal to or greater than the Ϫ3828/ϩ5LUC construct. These data indicate that DNA sequences between Ϫ3828 and Ϫ1131 bp are not required to direct tissue-specific expression of the human GnRH gene to the hypothalamus and also are not required for basal expression of this transgene in mice. In contrast, the Ϫ484/ϩ5LUC construct is not expressed in either the hypothalamus or the olfactory lobes, but expression was found in a mesenteric tumor (Fig. 1c) . These results indicate that DNA sequences between Ϫ1131 and Ϫ484 bp of the promoter are essential to direct appropriate tissue-specific expression of the hGnRH gene in transgenic mice to rostral brain regions and suggest that dis- 
crete cis-acting regulatory regions controlling GnRH gene expression are located in these DNA sequences.
Human GnRH Promoter DNA Fragments Are Essential to Target Luciferase Expression to GnRH
Neurons-To further localize transgene expression of the Ϫ3828/ϩ5LUC construct, the preoptic area, more caudal hypothalamic tissue, and the olfactory lobes were excised and assayed separately. Fig. 2 demonstrates that the majority of expression in either agematched male or female adult animals was localized to the preoptic area. In keeping with expression of the GnRH gene in the mouse, more caudal regions of the hypothalamus and olfactory cortex also expressed significant luciferase activity.
To confirm that luciferase expression was localized to the GnRH neuron, in situ hybridization histochemical analysis of the rostral hypothalamus was performed in transgenic animals. Antisense probes to luciferase and mouse GnRH cDNA were hybridized to tissue sections. Fig. 3 is a representative tissue section through the OVLT of an animal bearing the Ϫ3828/ϩ5LUC transgene. Colocalization of GnRH (digoxigenin-labeled probe, purple) and luciferase ( 35 S-labeled probe, silver grains) is demonstrated. Luciferase and GnRH probe hybridization colocalized to neurons in the OVLT and to a lesser extent in the caudal hypothalamus and olfactory lobes, appropriate regions for GnRH expression (5, 44) . These studies demonstrated that luciferase and GnRH mRNA are consistently coexpressed in the same neurons and that physiologically relevant regulation of endogenous GnRH gene transcription can be evaluated by measurement of the luciferase reporter construct expression.
Sex-specific Differences in Regulation of the hGnRH Gene in Transgenic Animals-8-to 10-week-old adult mice from the same founder line underwent gonadectomy or sham surgery. 2 weeks after surgery, gonadectomized male and female animals were given replacement testosterone or estrogen, respectively. 14 days after replacement, animals were sacrificed and hypothalamic tissue was assayed for luciferase activity. Fig. 4 , a and b, shows hypothalamic luciferase activity from Ϫ3828/ϩ5LUC transgenic adult female and male animals, respectively, after sham surgery, gonadectomy, or gonadectomy and sex steroid replacement. Fig. 4a demonstrates that gonadectomy in females is associated with a significant increase in hypothalamic luciferase activity, and chronic estrogen replacement therapy resulted in a suppression of luciferase activity. In the olfactory lobe, gonadectomy also increased luciferase activity, and estrogen replacement returned luciferase activity back to control levels. These data suggest that estrogen, acting either directly on the GnRH neuron or indirectly via interneuronal pathways, can modulate the transcriptional activity of the hGnRH gene.
The data also demonstrated that castration of males resulted in some increased luciferase expression when compared with sham castrated males. Testosterone-treated castrated males expressed luciferase at levels not significantly different from those of sham castrated animals. These results suggest that testosterone may have inhibitory effects on GnRH transcription in male mice, but its effects were not as profound as those of estrogen in female animals. This sex difference is unlikely to be attributable to an insufficient efficacy of the testosterone treatment versus the estrogen treatment since radioimmunoassay measurements of serum testosterone and ␤-estradiol indicate that levels in steroid capsule-treated animals were between 6-and 22-fold higher than those seen in intact animals.
Developmental Regulation of the hGnRH Gene in Transgenic Animals-To understand how GnRH gene transcription varies with development, hypothalamic expression of luciferase was measured in transgenic animals bearing the Ϫ3828/ϩ5LUC or the Ϫ1131/ϩ5LUC transgene through development. Fig. 5 demonstrates hypothalamic luciferase activity during development of the Ϫ1131/ϩ5LUC animals. Note that luciferase activity rises during the first few days of life and peaks around day 10, approximately 10 -15 days before the first external signs of puberty in the mouse. Hypothalamic luciferase activity subsequently falls to adult levels after day 18. Therefore, peak luciferase activity, which is an indirect measure of GnRH gene transcription, is noted significantly before the onset of puberty in these animals. Similar results were obtained in Ϫ3828/ ϩ5LUC transgenic animals (data not shown). These data indicate that GnRH gene transcription can be modulated during development by as little as a Ϫ1131 to ϩ5 bp of the hGnRH promoter and suggest that cis-acting elements mediating these developmental responses are located within this promoter region.
DISCUSSION
The appropriate expression and release of GnRH from neurons in the hypothalamus are vital for the elaboration of normal reproductive function in mammals. In the mouse, presumptive GnRH neurons arise from cells in the olfactory placode. They migrate during development to their final location in the hypothalamus. The initiation of GnRH expression starts during this period of cellular migration at about prenatal day 10 (4). In the adult, GnRH expression is located primarily in the rostral hypothalamus with additional neurons located in the migratory pathway within olfactory regions. In the present study, we have used the luciferase reporter gene as a cellular marker for expression and fused it to varying segments of the GnRH promoter. Both a Ϫ3828 to ϩ5-and a Ϫ1131 to ϩ5-bp region of the promoter were essential to direct expression of a luciferase reporter gene to hypothalamic neurons and to a lesser extent to neurons of the olfactory cortex (Fig. 1, a and b,  respectively) . However, a Ϫ484 to ϩ5-bp fragment of the promoter did not target luciferase expression in the hypothalamus or olfactory cortex (Fig. 1c) . Therefore, we have demonstrated that tissue-specific expression of the GnRH gene is mediated by a 647-bp fragment (Ϫ1131 to Ϫ484 bp) of the proximal promoter of the human GnRH gene.
Cell-specific expression of the luciferase reporter gene was demonstrated with double-labeled in situ hybridization (Fig. 3) . Analysis of histological sections revealed that GnRH expression in the Ϫ3828/ϩ5LUC animals and luciferase expression were colocalized in rostral hypothalamic tissue. GnRH staining and luciferase staining were never observed independently of each other. There were very low but detectable levels of luciferase expression in other tissues, and it is possible that expression of luciferase in non-hypothalamic tissue may have occurred in cells that were not expressing GnRH. However, these data confirm that cell-specific expression of hGnRH gene has been obtained in transgenic animals.
Recent work in the GT1 cell line, a mouse GnRH cell line that was developed by targeting the SV40 large T antigen to GnRH neurons with the rat GnRH promoter, found that cell-specific expression in the rat may require cis-regulatory regions more 5Ј to what is needed to target the GnRH gene using the hGnRH promoter. The results obtained in the GT1 cell line have suggested that a cis-regulatory element located between Ϫ1863 and Ϫ1571 bp of the rat GnRH gene is necessary for the cell-specific expression of GnRH (26) . By using DNase I footprinting and scanning replacement mutagenesis, several regions were found to be important for in vitro GnRH expression, FIG. 3 . Coronal section cut at the level of the OVLT of a ؊3828/ ؉5LUC transgenic mouse (one of four examined) and stained for GnRH and luciferase expression by in situ hybridization. GnRH expression is indicated by purple-staining digoxigenin-labeled probe, and luciferase expression appears as silver grains ( 35 S-labeled probe). All cells that expressed GnRH also expressed luciferase, and all cells that expressed luciferase also expressed GnRH. Two Ϫ1131/ ϩ5LUC animals were examined as well, and the results were the same. and it was postulated that several different transcription factors might interact at these sites to regulate gene expression. While the rat enhancer is in a different location than the cell-specific element in the hGnRH gene, there is significant homology (54%) between the cis-regulatory elements in the rat gene and the region of the human GnRH promoter demonstrated in the present studies to be necessary for the cellspecific expression of GnRH (Ϫ1131 to Ϫ484 bp upstream of the hypothalamic transcriptional start site). It is unclear at this time whether this discrepancy in localization of cell-specific elements between the human and rat GnRH genes represents a species-specific difference.
Interestingly, the hGnRH cell-specific element contains several consensus binding sequences for POU homeodomain proteins, which in other systems have been demonstrated to act as cell-specific transcriptional activators (23, 24) . Specifically, Brn-2 and Brn-3 sites were noted between Ϫ959 and Ϫ493 bp of the hGnRH gene. The corticotropin-releasing factor gene contains several Brn-2 DNA-binding sites, and Brn-2 has been shown to regulate the expression of the corticotropin-releasing factor gene (25) . There are also two consensus Oct-1/Oct-2-binding sites located between Ϫ838 and Ϫ735 bp. Oct-1 has been proposed as an activator of immunoglobulin gene expression, and Oct-2 appears to be ubiquitously expressed (27, 28) . Recently, Oct-1 has been shown to bind to the enhancer in the rat GnRH gene and increase gene transcription (29) . Lymphocytes have been reported to express GnRH, and this site may function as a cis-acting element controlling expression in these cells (30) . At this time, however, it is unclear whether these particular sites are involved in regulating expression of the hGnRH gene.
There is great debate concerning the effects of the gonadal steroids on GnRH expression. It has been reported that estradiol inhibits (31, 32) , has no effect (33) (34) (35) (36) , stimulates (37) (38) (39) (40) (41) , or has variable effects (42) on GnRH expression. The variable results in females are most likely due to differences in the experimental paradigms used and to the well characterized positive and negative feedback effects that estradiol has demonstrated to exert on GnRH neurons. However, most studies with chronic estrogen treatment in vivo suggest that GnRH expression is inhibited. Our results in the present study demonstrate that ␤-estradiol decreased expression of GnRH gene transcription, as measured by the luciferase reporter gene. Luciferase expression in females 2 weeks after ovariectomy was significantly higher than in intact females. When ovariectomized females were treated with estradiol, luciferase expression values were significantly lower than those seen in either gonadectomized or intact animals. These data indicated that estrogen can modulate the hGnRH gene promoter through either a direct action on the GnRH neuron or via other neuronal connections and that estrogen-responsive elements are contained within 3828 base pairs upstream of the hGnRH gene. There has also been a divergence of opinion regarding the effect of testosterone on GnRH expression (32, 34) . Our results demonstrate that testosterone also has a significant effect on luciferase expression in males, although this effect was less profound than the effects of estrogen in the females. It is not clear whether these differences are due to an inherent disparity between androgen-and estrogen-mediated regulation of GnRH.
The onset of GnRH expression in the mouse is seen in the olfactory pit between day 10 and day 11 of embryological life (4) . The bulk of GnRH-expressing neurons then migrate to their final location in the rostral forebrain. After birth, GnRH expression in the rat was found to increase sharply some 20 days before the onset of puberty and to decline to more moderate levels thereafter (43) . Results from the present study indicate that the hypothalamic expression of GnRH gene in the mouse, as expected, has a similar temporal pattern of expression as that of the rat with a sharp transient increase in luciferase expression observed at 10 days, which is about 10 -15 days before the beginning of reproductive function of the mice in our colony. Increased expression of GnRH is probably important for the increased production and release of GnRH that may trigger the initiation of reproductive viability. Our results suggest, but do not prove, that the increase in GnRH expression observed prior to puberty may be mediated by an increase in GnRH gene transcription.
In conclusion, our results clearly demonstrate that cell-specific in vivo expression of the human GnRH gene can be obtained with a region of the promoter between Ϫ1131 and ϩ5 bp. A further deletion of this gene localizes a cell-specific element of the hGnRH gene to a region between Ϫ1131 and Ϫ484 bp. The elements responsible for the functional regulation of GnRH gene expression within this region have not yet been elucidated, but this region contains several DNA-binding site homologies for Oct-1, Oct-2, Brn-2, and Brn-3. It is tempting to speculate that the POU homeodomain family of transcription factors may have a role in the regulation of GnRH gene expression in the hypothalamus. Further studies will be necessary to prove or disprove this hypothesis.
